Practice Point®: Rare Diseases
In these podcasts, we dive deep into the world of rare diseases, where every story is unique and every diagnosis a challenge. The episodes highlight the personal journeys of patients and medical professionals as they navigate the complexities of rare conditions. Each episode features expert insights on cutting-edge research, emerging treatments, and the social and emotional aspects of living with a rare disease. These podcasts are your guide to understanding and advocating for those affected by these often misunderstood conditions.
Episode 33 - Advanced Therapies and the Future of Uncontrolled Gout
Managing uncontrolled gout isn’t always straightforward—especially when flares persist, comorbidities complicate care, or standard therapies fall short. As our understanding of gout expands beyond just elevated uric acid, clinicians are being asked to think differently, integrating immune pathways, real-world evidence, and emerging treatments into everyday practice.
From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026, this CME-accredited podcast explores how to approach these complex cases with greater clarity and confidence. Featuring expert insights and the latest clinical evidence, each episode dives into practical strategies across the continuum of gout care.
Listeners will hear discussions on a...
Episode 32 - Optimizing Gout Care Across the Disease Continuum
Managing uncontrolled gout isn’t always straightforward—especially when flares persist, comorbidities complicate care, or standard therapies fall short. As our understanding of gout expands beyond just elevated uric acid, clinicians are being asked to think differently, integrating immune pathways, real-world evidence, and emerging treatments into everyday practice.
From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026, this CME-accredited podcast explores how to approach these complex cases with greater clarity and confidence. Featuring expert insights and the latest clinical evidence, each episode dives into practical strategies across the continuum of gout care.
Listeners will hear discussions on a...
Episode 31 - Beyond the Joint: The Burden and Biology of Uncontrolled Gout
Managing uncontrolled gout isn’t always straightforward—especially when flares persist, comorbidities complicate care, or standard therapies fall short. As our understanding of gout expands beyond just elevated uric acid, clinicians are being asked to think differently, integrating immune pathways, real-world evidence, and emerging treatments into everyday practice.
From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026, this CME-accredited podcast explores how to approach these complex cases with greater clarity and confidence. Featuring expert insights and the latest clinical evidence, each episode dives into practical strategies across the continuum of gout care.
Listeners will hear discussions on a...
Episode 30 - Days 3 and 4: Key Breakthroughs from EASL 2026
These podcast episodes explore the rapidly evolving treatment landscape of Primary Biliary Cholangitis, highlighting recent therapeutic advances and reviews emerging clinical evidence on promising investigational therapies.
Designed for healthcare professionals, these episodes provides expert commentary on the latest cutting-edge data presented at EASL Congress 2026. Through an engaging podcast format, listeners will gain practical insights into how new evidence can inform personalized treatment strategies, support improved patient outcomes, and enhance the overall quality of care for people living with PBC.
Launch Date/Release: June 3, 2026
Expiration Date: May 31, 2027
FACULTY<...
Episode 29 - Days 1 and 2: Key Breakthroughs from EASL 2026
These podcast episodes explore the rapidly evolving treatment landscape of Primary Biliary Cholangitis, highlighting recent therapeutic advances and reviews emerging clinical evidence on promising investigational therapies.
Designed for healthcare professionals, these episodes provides expert commentary on the latest cutting-edge data presented at EASL Congress 2026. Through an engaging podcast format, listeners will gain practical insights into how new evidence can inform personalized treatment strategies, support improved patient outcomes, and enhance the overall quality of care for people living with PBC.
Launch Date/Release: June 3, 2026
Expiration Date: May 31, 2027
FACULTY<...
Episode 28 - NF1-PN Podcast: Key Advances from AAN 2026
Leveraging emerging evidence presented at AAN, Dr. Angela Hirbe provides synthesis of key findings, highlight their relevance across pediatric and adult care, and frame practical considerations for patient assessment and longitudinal management.
Launch/Release Date: April 24, 2026
Activity Expiration Date: March 31, 2027
FACULTY
Angela Hirbe, MD, PhD
Associate Professor of Medicine and Pediatrics
Director, Adult Neurofibromatosis Clinical Program
Division of Oncology, Sarcoma Section
Washington University School of Medicine
St. Louis, Missouri
This podcast provides accredited continuing education...
Episode 27 - MG Podcast: Emerging Insights from AAN 2026
Clinical care for myasthenia gravis is entering a period of meaningful progress, with growing opportunities to improve how the disease is diagnosed, assessed, and treated. Increased awareness of disease heterogeneity and the expanding use of standardized severity assessments are helping clinicians better define disease burden and guide management decisions.
In this 20-minute podcast episode, Dr. James Howard Jr. provides comprehensive coverage of key MG presentations, scientific symposia, posters, and abstracts presented at AAN 2026.
Launch/Release Date: April 23, 2026
Activity Expiration Date: March 31, 2027
FACULTY
James F. Howard...
Episode 26 - Patient-Focused Strategies to Effectively Diagnose, Treat, and Manage NF1-PN
This activity will provide a comprehensive overview of NF1-PN and will dive deeper into the nuances of treating and managing adult patients with inoperable symptomatic NF1-PN. Dr. Angela Hirbe will use clinical cases to illustrate best-practice approaches to optimally identify adult patients with NF1-PN that will benefit from approved MEK inhibitors and will detail how to choose between agents and address/prevent adverse effects. The work-up and monitoring recommendations will also be discussed and any insights for achieving improved outcomes among diverse patients will be detailed. This presentation will empower participants to make informed clinical decisions...
Episode 25 - Recent Progress in NF1-PN: Pathophysiology, Role of MEK Inhibitors, Recognizing the NF1-PN Patient
This activity will inform participants about the complex pathophysiology of NF1-PN and how an understanding of molecular pathways has led to the development of MEK inhibitors. The key published and ongoing clinical evidence on the utility of approved and emerging therapies for NF1-PN will be detailed to provide a strong foundation for clinical decision-making. An in-depth guide to recognize and diagnose patients with NF1-PN will also be discussed in this module to facilitate an accurate and timely diagnosis. Overall, this presentation will ensure that participants appreciate the need to recognize and treat NF1-PN among pediatric...
Episode 24 - Precision in Practice: Elevating Care for Uncontrolled Gout
Gout remains the most common form of inflammatory arthritis in adults, yet it continues to be one of the most misunderstood and mismanaged chronic diseases in clinical practice. Despite clear treatment guidelines and a growing array of therapeutic options, a substantial proportion of patients experience persistent flares, disease progression, and comorbid complications due to clinical inertia, fragmented care, and limited provider awareness of emerging innovations. This podcast, presented by Dr. Robert Terkeltaub, seeks to modernize clinical approaches to gout, accelerate the adoption of new evidence and therapies, and ultimately improve the quality and consistency of care for a patient...
Episode 23 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 7 - The Future of Stroke Prevention - What's Next?
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
Release Date: August 25, 2025
Expiration Date: July 31, 2026
FACULTY
C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC
In...
Episode 22 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 6 - Case Study Challenge - Applying Knowledge to Patient Care
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
Release Date: August 25, 2025
Expiration Date: July 31, 2026
FACULTY
C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC
In...
Episode 21 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 5 - Practical Considerations - How Will FXIa Inhibitors Fit Into Stroke Prevention?
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
Release Date: August 25, 2025
Expiration Date: July 31, 2026
FACULTY
C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC
In...
Episode 20 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 4 - Clinical Data Deep Dive - What Clinical Trials Tell Us
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
Release Date: August 25, 2025
Expiration Date: July 31, 2026
FACULTY
C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC
In...
Episode 19 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 3 - Understanding Residual Stroke Risk and the Consequences of Undertreatment
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
Release Date: August 25, 2025
Expiration Date: July 31, 2026
FACULTY
C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC
In...
Episode 18 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 2 - FXIa Inhibition - A New Paradigm in Stroke Prevention
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
Release Date: August 25, 2025
Expiration Date: July 31, 2026
FACULTY
C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC
In...
Episode 17 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 1 - The Unmet Needs in Stroke Prevention
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
Release Date: August 25, 2025
Expiration Date: July 31, 2026
FACULTY
C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC
In...
Episode 16 - Neurofibromatosis Type 1-related Plexiform Neurofibromas: Key Advances from the 2025 Annual Oncology Conference (Chicago)
The introduction of kinase inhibitors has significantly impacted the treatment landscape of plexiform neurofibromas (PN) associated with neurofibromatosis type 1 (NF1). In this podcast activity from the 2025 Annual Oncology Meeting, noteworthy data in NF1-PN has been summarized and evaluated by Dr. Amy Armstrong. This activity is AMA/ABS/ANCC/ACPE accredited for one-year.
Launch Date: June 5, 2025
Release Date: June 5, 2025
Expiration Date: May 31, 2026
FACULTY
Amy Armstrong, MD
Assistant Professor of Pediatrics
Division of Hematology/Oncology
Neurofibromatosis (NF) Center
...
Episode 15 - Clinical Clips from EASL Congress 2025: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 2
There continues to be significant progress in the treatment of primary biliary cholangitis (PBC) and these Clinical Clips from EASL 2025 have focused on the most impactful data presented at this conference. Dr. Nancy Reau will summarize key advances from Day 2 of EASL 2025 and describe their implications for clinical practice.
Launch Date: May 13, 2025
Release Date: May 13, 2025
Expiration Date: April 30, 2026
FACULTY
Nancy Reau, MD
Section Chief Professor of Medicine
Richard B. Capps MD, Professorship of Hepatology
Rush University Medical Center
<...Episode 14 - Clinical Clips from EASL Congress 2025: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 1
There continues to be significant progress in the treatment of primary biliary cholangitis (PBC) and these Clinical Clips from EASL 2025 have focused on the most impactful data presented at this conference. Dr. Nancy Reau will summarize key advances from Day 1 of EASL 2025 and describe their implications for clinical practice.
Launch Date: May 13, 2025
Release Date: May 13, 2025
Expiration Date: April 30, 2026
FACULTY
Nancy Reau, MD
Section Chief Professor of Medicine
Richard B. Capps MD, Professorship of Hepatology
Rush University Medical Center
<...Episode 13 - Emerging Evidence in Myasthenia Gravis: Key Updates from AAN 2025
In this podcast titled "Emerging Evidence in Myasthenia Gravis: Key Updates from AAN 2025," Dr. Nicholas Silvestri provides healthcare professionals with an actionable update on recent advancements in MG; which features insights from groundbreaking research presented at AAN 2025.
Launch Date: April 30, 2025
Release Date: April 30, 2025
Expiration Date: March 31, 2026
FACULTY
Nicholas Silvestri, MD, FAAN
Professor of Neurology, Associate Dean for Student and Academic Affairs
Department of Neurology
Jacobs School of Medicine & Biomedical Sciences
This podcast provides accredited continuing education credits. To receive your credit...
Episode 12 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 4 The Future of MG Care: Innovations in Diagnostics and Guidelines
Join Dr. Nicholas Silvestri in this 8-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, The Future of MG Care: Innovations in Diagnostics and Guidelines, looks ahead at emerging technologies and the need for standardized international guidelines to harmonize MG management.
Launch Date: April 28, 2025
Release Date: April 28, 2025
Expiration Date: March 31, 2026
FACULTY
Nicholas Silvestri, MD, FAAN
Professor of Neurology, Associate Dean for Student and Academic Affairs
Department of Neurology
Jacobs School of Medicine & Biomedical Sciences
This podcast provides ac...
Episode 11 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 3 Tailoring Treatment: The Role of Serotype Testing
Join Dr. Nicholas Silvestri in this 9-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Tailoring Treatment: The Role of Serotype Testing, discusses the impact of serotype testing on treatment decisions, including differences in therapeutic approaches for AChR-positive, MuSK-positive, and LRP4-positive patients.
Launch Date: April 24, 2025
Release Date: April 24, 2025
Expiration Date: March 31, 2026
FACULTY
Nicholas Silvestri, MD, FAAN
Professor of Neurology, Associate Dean for Student and Academic Affairs
Department of Neurology
Jacobs School of Medicine & Biomedical Sciences
This po...
Episode 10 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 2 Innovations in MG Therapeutics
Join Dr. Nicholas Silvestri in this 10-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Innovations in MG Therapeutics, focuses on the latest therapies, including complement inhibitors and FcRn antagonists, and their application in personalized treatment plans.
Launch Date: April 21, 2025
Release Date: April 21, 2025
Expiration Date: March 31, 2026
FACULTY
Nicholas Silvestri, MD, FAAN
Professor of Neurology, Associate Dean for Student and Academic Affairs
Department of Neurology
Jacobs School of Medicine & Biomedical Sciences
This podcast provides accredited continuing education credits. To...
Episode 9 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 1 Advancements in Myasthenia Gravis Diagnosis
Join Dr. Nicholas Silvestri in this 8-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Advancements in Myasthenia Gravis Diagnosis, highlights the limitations of traditional diagnostic methods and introduces emerging technologies such as high-sensitivity serotype testing and advanced neurophysiological techniques.
Launch Date: April 17, 2025
Release Date: April 17, 2025
Expiration Date: March 31, 2026
FACULTY
Nicholas Silvestri, MD, FAAN
Professor of Neurology, Associate Dean for Student and Academic Affairs
Department of Neurology
Jacobs School of Medicine & Biomedical Sciences
This podcast provides accredited co...
Episode 8 - Integrating Practice-Changing Updates to Improve Outcomes Among Patients
Please refer to the activity landing page for the downloadable slides.
Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune liver disease that can progress to end-stage liver disease. Recent developments have led to important updates in the diagnosis and use of novel approaches in treatment for patients with PBC. This podcast will utilize case-based discussion to address implications of risk stratification and practice-changing evidence for the long-term management among diverse patients with PBC.
Launch Date: January 21, 2025
Release Date: January 21, 2025
Expiration Date: December 31, 2025
...
Episode 7 - Clinical Clips® from AASLD 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 2
Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies were presented at AASLD 2024. In these podcasts, Dr. Ashwani K. Singal will discuss the most important breakthroughs in the understanding and treatment of PBC and will provide guidance on their impact.
Launch Date: November 26, 2024
Release Date: November 26, 2024
Expiration Date: October 31, 2025
FACULTY
Ashwani K. Singal, MD, MS, FACG, FAASLD, AGAF
Professor of Medicine, University of Louisville
Transplant Hepatologist and Staff Physician
Traeger Transplant Center and Jewish Hospital<...
Episode 6- Clinical Clips® from AASLD 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 1
Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies were presented at AASLD 2024. In these podcasts, Dr. Ashwani K. Singal will discuss the most important breakthroughs in the understanding and treatment of PBC and will provide guidance on their impact.
Launch Date: November 26, 2024
Release Date: November 26, 2024
Expiration Date: October 31, 2025
FACULTY
Ashwani K. Singal, MD, MS, FACG, FAASLD, AGAF
Professor of Medicine, University of Louisville
Transplant Hepatologist and Staff Physician
Traeger Transplant Center and Jewish Hospital<...
Episode 5 - Patient Voices in Primary Biliary Cholangitis: A CE Podcast Series to Recognize Challenges, Reduce Disparities, and Improve Outcomes - Part 3: Woman with PBC Requiring 2nd-Line Therapy
This podcast features an engaging discussion between Dr. Douglas Dieterich and his patient with long-standing PBC, on the patient’s insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.
Launch Date: November 21, 2024
Release Date: November 21, 2024
Expiration Date: October 31, 2025
FACULTY
Douglas Dieterich, MD
Director, Institute for Liver Medicine at Mount Sinai
Professor of Medicine, Icahn School of...
Episode 4 - Patient Voices in Primary Biliary Cholangitis: A CE Podcast Series to Recognize Challenges, Reduce Disparities, and Improve Outcomes - Part 2: Comorbidities and PBC
This podcast features an engaging discussion between Dr. David Victor and his patient, with long-standing PBC, on the patient’s insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.
Launch Date: October 24, 2024
Release Date: October 24, 2024
Expiration Date: September 30, 2025
FACULTY
David W. Victor III, MD
Associate Professor of Clinical Medicine
Houston Methodist Research Institute
As...
Episode 3 - Patient Voices in Primary Biliary Cholangitis: A CE Podcast Series to Recognize Challenges, Reduce Disparities, and Improve Outcomes - Part 1: Long-Standing PBC
This podcast features an engaging discussion between Dr. Douglas Dieterich and his patient, a 54-year-old woman with long-standing PBC, on the patient’s insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.
Launch Date: August 21, 2024
Release Date: August 21, 2024
Expiration Date: July 31, 2025
FACULTY
Douglas Dieterich, MD
Director, Institute for Liver Medicine at Mount Sinai
Professor of Me...
Episode 2 - Podcast from EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 2
Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies will be presented at the annual European Association for the Study of the Liver (EASL) 2024 Congress in Milan, Italy. In this podcast series, Dr. Kris Kowdley will discuss the most important breakthroughs in the understanding and treatment of PBC presented at the EASL Congress 2024 and will provide guidance on their impact.This is an accredited continuing education podcast as downloadable audio file (MP3) available for AMA/ABS/ANCC/ACPE credit.
Launch Date: June 11, 2024
Release Date: June 11, 2024
Expiration Date...
Episode 1 -Podcast from EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 1
Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies will be presented at the annual European Association for the Study of the Liver (EASL) 2024 Congress in Milan, Italy. In this podcast series, Dr. Kris Kowdley will discuss the most important breakthroughs in the understanding and treatment of PBC presented at the EASL Congress 2024 and will provide guidance on their impact.This is an accredited continuing education podcast as downloadable audio file (MP3) available for AMA/ABS/ANCC/ACPE credit.
Launch Date: June 11, 2024
Release Date: June 11, 2024
Expiration Date...
